Clinical insignificance of [18F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation-Reference-Cited by-同舟云学术

Clinical insignificance of [18F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation

Published:2021-06-16 Issue:13 Volume:48 Page:4495-4507
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Arnfield Evyn G.^ORCID,Thomas Paul A.,Roberts Matthew J.,Pelecanos Anita M.,Ramsay Stuart C.,Lin Charles Y.,Latter Melissa J.,Garcia Peter L.,Pattison David A.

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00259-021-05456-3.pdf

Reference37 articles.

1. Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. The Lancet. 2020;395:1208–16. https://doi.org/10.1016/S0140-6736(20)30314-7.

2. Kesch C, Kratochwil C, Mier W, Kopa K and Giesel FL. Gallium-68 or fluorine-18 for prostate cancer imaging? J Nucl Med. 2017:687-8.

3. Dietlein F, Kobe C, Hohberg M, Zlatopolskiy BD, Krapf P, Endepols H, et al. Intraindividual comparison of 18 F-PSMA-1007 with renally excreted PSMA ligands for PSMA PET imaging in patients with relapsed prostate cancer. J Nucl Med. 2020;61:729.

4. Derlin T, Weiberg D, von Klot C, Wester HJ, Henkenberens C, Ross TL, et al. (68)Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging. Eur Radiol. 2016;26:4345–53. https://doi.org/10.1007/s00330-016-4308-4.

5. Fennessy N, Lee J, Shin J, Ho B, Ali SA, Paschkewitz R, et al. Frusemide aids diagnostic interpretation of (68) Ga-PSMA positron emission tomography/CT in men with prostate cancer. J Med Imaging Radiat Oncol. 2017;61:739–44. https://doi.org/10.1111/1754-9485.12625.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [¹⁸F]PSMA-1007 PET/CT;Journal of Nuclear Medicine;2024-09-05

2. Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review—Part 1 oncological setting;Clinical and Translational Imaging;2024-08-05

3. Cutting back on overdiagnosis – Occam’s Razor and unspecific bone uptakes in PSMA PET;European Journal of Nuclear Medicine and Molecular Imaging;2024-07-23

4. Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer;Nature Reviews Urology;2024-07-08

5. Prostate-specific Membrane Antigen;PET Clinics;2024-07